SAN JOSE, Calif.--(BUSINESS WIRE)--HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) to supply the HemoSense portable INRatio® PT/INR monitoring system to identified LabCorp laboratories. The INRatio system will also be made available to selected LabCorp patient service centers and affiliated physician offices nationwide.
